Clinical Trials on Cholangitis, Sclerosing in Japan
Total 71 results
-
Mayo ClinicNagoya UniversityCompletedIgG4-related Disease | IgG4-related Sclerosing CholangitisUnited States, Japan
-
Gilead SciencesTerminatedPrimary Sclerosing CholangitisUnited States, Belgium, Israel, Spain, United Kingdom, Australia, Germany, New Zealand, Denmark, France, Japan, Switzerland, Austria, Canada, Finland, Italy
-
Kiminori Kimura, MDJapan Agency for Medical Research and Development; Ohara Pharmaceutical Co....CompletedLiver Cirrhosis, Biliary | Primary Biliary Cholangitis (PBC)Japan
-
Kowa Research Institute, Inc.Recruiting
-
Teikyo UniversityCompletedPrimary Biliary CirrhosisJapan
-
National Center of Neurology and Psychiatry, JapanCompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveJapan
-
Mitsubishi Tanabe Pharma CorporationCompletedAmyotrophic Lateral Sclerosis (ALS)Japan
-
Yoshino Neurology ClinicUnknownAmyotrophic Lateral SclerosisJapan
-
Gunma UniversityCompletedSystemic Sclerosis Patients With Digital UlcersJapan
-
Maruho Co., Ltd.Active, not recruiting
-
Chiba UniversityCompleted
-
EA Pharma Co., Ltd.TerminatedPrimary Biliary CholangitisJapan
-
TakedaCompleted
-
Mitsubishi Tanabe Pharma CorporationCompletedAmyotrophic Lateral Sclerosis (ALS)Japan
-
Kyowa Kirin Co., Ltd.Active, not recruiting
-
Kyoto UniversityPfizer; Kitasato University; Tokushima University; Tottori UniversityRecruiting
-
Mitsubishi Tanabe Pharma CorporationCompletedJapanese Patients With ALSJapan
-
Mitsubishi Tanabe Pharma CorporationCompletedJapanese Patients With ALSJapan
-
GlaxoSmithKlineCompletedCholestasisUnited States, Australia, France, Spain, Germany, Canada, Japan, United Kingdom, Italy, Poland
-
NobelpharmaCompletedPlaque | Tuberous Sclerosis | Angiofibroma | Hypomelanotic MaculeJapan
-
NobelpharmaCompletedPlaque | Tuberous Sclerosis | Angiofibroma | Hypomelanotic MaculeJapan
-
GlaxoSmithKlineRecruitingPruritusUnited States, France, Italy, Japan, Spain, United Kingdom, Bulgaria, Germany, Greece, China, Argentina, Belgium, Brazil, Canada, Czechia, Israel, Mexico, Poland, Russian Federation, Switzerland
-
Tokyo UniversityJapan Agency for Medical Research and Development; Zenyaku Kogyo Co., Ltd.CompletedAutoimmune Diseases | Collagen Diseases | Scleroderma, Systemic | Lung Fibrosis | Skin SclerosisJapan
-
Kyowa Kirin Co., Ltd.Active, not recruitingModerate to Severe Systemic SclerosisJapan
-
Mitsubishi Tanabe Pharma CorporationRecruiting
-
NobelpharmaActive, not recruitingTuberous Sclerosis ComplexJapan
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
Tokyo Medical UniversityCompleted
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisJapan
-
NovartisMitsubishi Tanabe Pharma CorporationCompleted
-
BiogenActive, not recruiting
-
University of TokushimaEisai Co., Ltd.UnknownAmyotrophic Lateral SclerosisJapan
-
BiogenCompleted
-
NovartisMitsubishi Tanabe Pharma CorporationCompletedMultiple SclerosisJapan
-
Novartis PharmaceuticalsCompletedRelapsing Multiple SclerosisJapan, Russian Federation
-
AmgenEnrolling by invitationDiffuse Cutaneous Systemic Sclerosis | Sclerosis, SystemicKorea, Republic of, France, United States, Spain, Mexico, Japan, Argentina, Greece, Israel
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisKorea, Republic of, Taiwan, Czechia, Japan, Poland
-
Novartis PharmaceuticalsTerminatedMultiple SclerosisBelgium, Spain, Russian Federation, France, Italy, Poland, Sweden, Turkey, Czech Republic, Japan
-
GlaxoSmithKlineRecruitingCholestasisUnited States, France, Japan, United Kingdom, Bulgaria, Germany, Greece, Italy, China, Argentina, Belgium, Brazil, Canada, Czechia, Israel, Mexico, Poland, Russian Federation, Spain, Switzerland
-
Novartis PharmaceuticalsActive, not recruitingRelapsing-remitting Multiple Sclerosis | Active Secondary Progressive Multiple SclerosisJapan
-
EMD SeronoMerck KGaA, Darmstadt, Germany; Ono Pharmaceutical Co. LtdTerminatedMultiple SclerosisUnited States, Belgium, Canada, Czech Republic, Germany, Japan, Poland, Russian Federation, Spain, Ukraine, Greece
-
Ono Pharma USA IncCompletedMultiple SclerosisUnited States, Belgium, Canada, Czech Republic, Germany, Greece, Japan, Poland, Russian Federation, Spain, Ukraine
-
AmgenRecruitingDiffuse Cutaneous Systemic Sclerosis | Sclerosis, SystemicUnited States, Korea, Republic of, Germany, Spain, Italy, Israel, Japan, Serbia, Argentina, Greece, Mexico, Poland, Chile, Austria, France, Portugal, Romania, Switzerland, United Kingdom
-
Mitsubishi Tanabe Pharma America Inc.CompletedAmyotrophic Lateral Sclerosis (ALS)United States, Canada, Japan, France, Germany, Italy
-
Corbus Pharmaceuticals Inc.TerminatedDiffuse Cutaneous Systemic SclerosisUnited States, Switzerland, Korea, Republic of, Australia, Netherlands, Israel, United Kingdom, Germany, Japan, Spain, Poland, Canada
-
GlaxoSmithKlineCompletedAmyotrophic Lateral SclerosisUnited States, France, Australia, Canada, Belgium, Germany, Korea, Republic of, Japan, Netherlands, Italy, United Kingdom
-
Eisai Co., Ltd.CompletedAmyotrophic Lateral Sclerosis (ALS)Japan
-
Eisai Co., Ltd.CompletedAmyotrophic Lateral Sclerosis (ALS)Japan
-
BiogenRecruitingRelapsing Forms of Multiple SclerosisChina, Japan
-
Apellis Pharmaceuticals, Inc.TerminatedMotor Neuron Disease | Amyotrophic Lateral SclerosisUnited States, Netherlands, Spain, Germany, Japan, Australia, France, Poland, Ukraine, Belgium, Czechia, Ireland, Italy, United Kingdom